Taiwan Bio-Manufacturing Corp (TBMC, 臺灣生物醫藥製造), a government-initiated biotech company, on Friday staged its first public event in Taipei, during which it outlined its business model as being similar to that of contract chipmaker Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and highlighted its strategic alliance with a US technology-focused biomanufacturing company.
The company, co-established by the Industrial Technology Research Institute (ITRI) and the Development Center for Biotechnology (DCB) last year, on Friday announced a strategic alliance with National Resilience Inc from the US, which it said would give it access to the latter’s expertise in biologics, vaccines, nucleic acids, cell therapy and gene therapy.
TBMC was started following the government’s realization during COVID-19 that Taiwan needed to have its own pharmaceutical manufacturing capabilities, Minister of National Development Kung Ming-hsin (龔明鑫) told a news conference in Taipei.
Photo courtesy of Taiwan Bio-Manufacturing Corp
“It is both a health issue and a national security issue,” he said.
The pandemic put Taiwan’s inability to mass produce mRNA vaccines under the spotlight, TBMC chairman and acting CEO Michel Chu (瞿志豪) said.
“Then-vice president Chen Chien-jen (陳建仁) and then-vice premier Shen Jong-chin (沈榮津) initiated a plan to start a company that specializes in the contract manufacturing of biologics, but can also manufacture vaccines during a pandemic,” Chu said in a video played at the news conference that introduced the company.
Chu also told the audience that the company plans to make the most of Taiwan’s advantages — abundant biotech talent and an outstanding smart manufacturing industry — to catapult the country into becoming a global market for contract development and manufacturing organizations (CDMOs).
CDMOs are companies that provide pharmaceutical companies with outsourcing options for drug development and manufacturing to lower risks and capital investment in advanced manufacturing processes.
TBMC is thus not only similar to TSMC in name, but also in its strategy of specializing in advanced contract manufacturing, Chu said.
The establishment of TBMC is based on the “successful experience” of TSMC, he added.
TBMC, like TSMC in 1986, was partly funded by the government, first employed talent from the ITRI — and also the DCB in the case of TBMC — and used foreign technologies and innovations “to secure the trust of future clients,” Chu said.
TSMC’s foreign partner back then was Royal Philips Electronics NV — which transferred some of its semiconductor patents to TSMC — while TBMC works with National Resilience.
“There are very few CDMOs in the world that out-license,” Chu said. “Many companies around the world would love for TSMC to authorize its advanced manufacturing technologies to them, but TSMC would definitely not be willing to do so.”
The reason TBMC was able to strike a deal with National Resilience was not just its special Taiwan connection — Resilience vice chairman Patrick Yang (楊育民) is Taiwanese American — but also because Taiwan has the exceptional automated and smart manufacturing capabilities that large-molecule drugs increasingly require, Chu said.
Large-molecule drugs, also known as biologics, are made from living organisms, while small-molecule drugs, which make up most of the pharmaceutical drugs on the market, are chemically synthesized.
Minister of Economic Affairs Wang Mei-hua (王美花) added that Taiwan has an edge when comes to talent, its medical system and protection of intellectual property, but “as the pharmaceutical industry is a field where big companies gain the most by remaining large, international collaboration is crucial for Taiwan’s biotech industry.”
CDMO shows great potential for biologics in Asia, Wang said, adding that TBMC has established a lab in the Taipei Bioinnovation Park and that it aims to have a Good Manufacturing Practices-grade factory in the Hsinchu Biomedical Science Park within two years.
“We’re hoping TBMC will become another ‘sacred mountain that protects the nation’ [as TSMC is referred to among Taiwanese] in the decades to come,” the minister said.
UNPRECEDENTED PACE: Micron Technology has announced plans to expand manufacturing capabilities with the acquisition of a new chip plant in Miaoli Micron Technology Inc unveiled a newly acquired chip plant in Miaoli County yesterday, as the company expands capacity to meet growing demand for advanced DRAM chips, including high-bandwidth memory chips amid the artificial intelligence boom. The plant in Miaoli County’s Tongluo Township (銅鑼), which Micron acquired from Powerchip Semiconductor Manufacturing Corp (力積電) for US$1.8 billion, is expected to make a sizeable capacity contribution to the company from fiscal 2028, the company said in a statement. It would be an extended production site of Micron’s large-scale manufacturing hub in Taichung, the company said. As the global semiconductor industry is racing to reach US$1 trillion
A man walks past real-estate advertisements outside a house in Taipei yesterday. The central bank yesterday said it plans to establish an “Inflation-at-Risk” gauge as a supplementary tool for observing inflation, as policymakers express wish to communicate more effectively with the public when making inflation forecasts.
ABOVE LEGAL REQUIREMENT: The Ministry of Economic Affairs is prepared if LNG supply is disrupted, with more than the legal requirement of 11 days of inventory Taiwan has largely secured liquefied natural gas (LNG) supplies through May and arranged about half of June’s supply, Minister of Economic Affairs Kung Ming-hsin (龔明鑫) said yesterday. Since the Middle East conflict began on Feb. 28, Taiwan’s LNG inventories have remained more than 12 days, exceeding the legal requirement of 11 days, indicating no major supply concerns for domestic gas and electricity, Kung said at a meeting of the legislature’s Economics Committee in Taipei. The ministry aims to increase the figure to 14 days by the end of next year, he said. While one or two LNG or crude oil shipments for May
Memory chip stocks extended their losses yesterday after Alphabet Inc’s Google publicized research that could allow more efficient use of the storage needed for artificial intelligence (AI) development. SK Hynix Inc and Samsung Electronics Co, South Korean leaders in the market, fell more than 6 percent and about 5 percent respectively in Seoul. In the US, Micron Technology Inc, Western Digital Corp and Sandisk Corp slid more than 2 percent in pre-market trading, after they all closed lower on Wednesday. Memory companies have been on a tear in recent months as the rapid development of AI infrastructure triggered a spike in chip
RSS